Fiche publication
Date publication
juin 2025
Journal
Inflammopharmacology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr PAIS DE BARROS Jean-Paul
Tous les auteurs :
Hecquet S, Totoson P, Martin H, Saas P, Pais-de-Barros JP, Tournier M, Prati C, Wendling D, Demougeot C, Verhoeven F
Lien Pubmed
Résumé
In patients with spondyloarthritis, intestinal permeability (IP) and bacterial translocation (BT) has been described as increased. Anti-inflammatory medications are known to induce deleterious intestinal changes in the general population, their effects in case of arthritis have been poorly studied.
Mots clés
Animal model, Anti-inflammatory drugs, Intestinal barrier, Intestinal permeability, Non-steroidal anti-inflammatory drugs, Spondyloarthritis
Référence
Inflammopharmacology. 2025 06 10;: